Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients

Author(s):  
Shun-ichi Kimura ◽  
Yoshinobu Kanda ◽  
Tatsuo Oyake ◽  
Hiroki Yamaguchi ◽  
Shin-ichiro Fujiwara ◽  
...  
2015 ◽  
Vol 53 ◽  
pp. 251-260 ◽  
Author(s):  
David Martinez ◽  
Michelle R. Ananda-Rajah ◽  
Hanna Suominen ◽  
Monica A. Slavin ◽  
Karin A. Thursky ◽  
...  

2011 ◽  
Vol 4 (1) ◽  
Author(s):  
Siok-Ying Lee ◽  
Chay-Leng Yeo ◽  
Winnie H Lee ◽  
Andrea L Kwa ◽  
Liang-Piu Koh ◽  
...  

2013 ◽  
Vol 51 (2) ◽  
pp. 150-154 ◽  
Author(s):  
I. Jarque ◽  
M. Tormo ◽  
J. L. Bello ◽  
M. Rovira ◽  
M. Batlle ◽  
...  

2008 ◽  
Vol 27 (8) ◽  
pp. 850-855 ◽  
Author(s):  
Fernanda P. Silveira ◽  
Eun J. Kwak ◽  
David L. Paterson ◽  
Joseph M. Pilewski ◽  
Kenneth R. McCurry ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Ian A. Myles ◽  
Satyen Gada

Patients with HIV/AIDS can present with multiple types of fungal rhinosinusitis, fungal balls, granulomatous invasive fungal rhinosinusitis, acute or chronic invasive fungal rhinosinusitis, or allergic fungal rhinosinusitis (AFRS). Given the variable spectrum of immune status and susceptibility to severe infection from opportunistic pathogens it is extremely important that clinicians distinguish aggressive fungal invasive fungal disease from the much milder forms such as AFRS. Here we describe a patient with HIV and AFRS to both remind providers of the importance of ruling out invasive fungal disease and outline the other unique features of fungal sinusitis treatment in the HIV-positive population. Additionally we discuss the evidence for and against use of allergen immunotherapy (AIT) for fungal disease in general, as well as the evidence for AIT in the HIV population.


2003 ◽  
Vol 22 (1) ◽  
pp. S193 ◽  
Author(s):  
M.L Plit ◽  
L.G Singleton ◽  
A Scott ◽  
S Rainer ◽  
M.A Malouf ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document